FI954394A - 17-desoksikortikosteroidi-21-(O)-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä - Google Patents

17-desoksikortikosteroidi-21-(O)-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä Download PDF

Info

Publication number
FI954394A
FI954394A FI954394A FI954394A FI954394A FI 954394 A FI954394 A FI 954394A FI 954394 A FI954394 A FI 954394A FI 954394 A FI954394 A FI 954394A FI 954394 A FI954394 A FI 954394A
Authority
FI
Finland
Prior art keywords
carboxylic acid
opt
deoxycorticosteroid
preparation
acid esters
Prior art date
Application number
FI954394A
Other languages
English (en)
Swedish (sv)
Other versions
FI114708B (fi
FI954394A0 (fi
Inventor
Ulrich Stache
Hans-Georg Alpermann
Manfred Bohn
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI954394A0 publication Critical patent/FI954394A0/fi
Publication of FI954394A publication Critical patent/FI954394A/fi
Application granted granted Critical
Publication of FI114708B publication Critical patent/FI114708B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI954394A 1994-09-20 1995-09-18 17-desoksikortikosteroidi-21-[O]-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä FI114708B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4433374 1994-09-20
DE4433374A DE4433374A1 (de) 1994-09-20 1994-09-20 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
FI954394A0 FI954394A0 (fi) 1995-09-18
FI954394A true FI954394A (fi) 1996-03-21
FI114708B FI114708B (fi) 2004-12-15

Family

ID=6528610

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954394A FI114708B (fi) 1994-09-20 1995-09-18 17-desoksikortikosteroidi-21-[O]-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä

Country Status (24)

Country Link
US (1) US5824670A (fi)
EP (1) EP0708111B1 (fi)
JP (1) JP3902255B2 (fi)
KR (1) KR100406627B1 (fi)
CN (1) CN1056151C (fi)
AT (1) ATE188480T1 (fi)
AU (1) AU695710B2 (fi)
CA (1) CA2158610C (fi)
CZ (1) CZ288297B6 (fi)
DE (2) DE4433374A1 (fi)
DK (1) DK0708111T3 (fi)
ES (1) ES2140596T3 (fi)
FI (1) FI114708B (fi)
GR (1) GR3032688T3 (fi)
HU (1) HU217438B (fi)
IL (1) IL115331A (fi)
NO (1) NO305210B1 (fi)
NZ (1) NZ280038A (fi)
PL (1) PL186071B1 (fi)
PT (1) PT708111E (fi)
RU (1) RU2161624C2 (fi)
SI (1) SI9500295B (fi)
TW (1) TW424094B (fi)
ZA (1) ZA957877B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2805832A1 (en) 2010-07-20 2012-01-26 Taro Pharmaceutical Industries Ltd. Process for the preparation of 17-desoxy-corticosteroids

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2755292A (en) * 1952-01-21 1956-07-17 Organon Labor Ltd Phenyl propionate of testosterone
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones
ES229413A1 (es) * 1956-06-22 1956-11-01 Francisco Vismara S P A UN PROCEDIMIENTO PARA LA PREPARACIoN DE COMPUESTOS ESTEROIDALES QUE CONTENGAN UN GRUPO CEToLICO EN LA CADENA LATERAL
DE1131668B (de) * 1959-07-16 1962-06-20 Leo Ab Verfahren zur Herstellung von Estern von Corticosteroid-Hormonen
CH495969A (de) * 1965-11-09 1970-09-15 Schering Ag Verfahren zur Herstellung neuer 21-Ester von 16a-Methyl-21-hydroxy- 1,4-steroiden
DE2047105C3 (de) * 1970-09-18 1979-02-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 17-Chlorsteroide und Verfahren zu ihrer Herstellung
US3956349A (en) * 1975-02-18 1976-05-11 Syntex (U.S.A.) Inc. Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
LU77457A1 (fi) * 1977-05-31 1979-01-19
US4377573A (en) * 1978-01-06 1983-03-22 Leveen Harry H Method of control of gastrointestinal bleeding
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2920726A1 (de) * 1979-05-18 1980-11-27 Schering Ag Neue kortikoide, ihre herstellung und verwendung
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8303031D0 (sv) * 1983-05-30 1983-05-30 Leo Ab Improved steroid esters preparation
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US4920114A (en) * 1988-06-28 1990-04-24 Merrell Dow Pharmaceuticals Inc. 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
NZ237559A (en) * 1990-04-02 1993-04-28 Merrell Dow Pharma Halogenoethyl steroid derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
CN1124250A (zh) 1996-06-12
FI114708B (fi) 2004-12-15
EP0708111B1 (de) 2000-01-05
HU217438B (hu) 2000-01-28
US5824670A (en) 1998-10-20
ES2140596T3 (es) 2000-03-01
ATE188480T1 (de) 2000-01-15
NO305210B1 (no) 1999-04-19
TW424094B (en) 2001-03-01
GR3032688T3 (en) 2000-06-30
CZ288297B6 (en) 2001-05-16
IL115331A0 (en) 1995-12-31
PL186071B1 (pl) 2003-10-31
HUT72969A (en) 1996-06-28
DE59507565D1 (de) 2000-02-10
ZA957877B (en) 1996-04-03
CN1056151C (zh) 2000-09-06
NZ280038A (en) 1997-03-24
AU695710B2 (en) 1998-08-20
PL310544A1 (en) 1996-04-01
EP0708111A1 (de) 1996-04-24
DE4433374A1 (de) 1996-03-21
RU2161624C2 (ru) 2001-01-10
DK0708111T3 (da) 2000-06-13
KR100406627B1 (ko) 2004-02-19
SI9500295A (en) 1996-04-30
FI954394A0 (fi) 1995-09-18
HU9502735D0 (en) 1995-11-28
CA2158610C (en) 2007-07-17
KR960010681A (ko) 1996-04-20
PT708111E (pt) 2000-04-28
CZ242595A3 (en) 1996-04-17
CA2158610A1 (en) 1996-03-21
IL115331A (en) 2002-07-25
SI9500295B (en) 2001-12-31
AU3172895A (en) 1996-04-04
JP3902255B2 (ja) 2007-04-04
JPH0899992A (ja) 1996-04-16
NO953695D0 (no) 1995-09-19
NO953695L (no) 1996-03-21

Similar Documents

Publication Publication Date Title
ATE71375T1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
FR2678938B1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
IL90062A0 (en) Pyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE121739T1 (de) Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.
ATE235482T1 (de) Isocumarinderivate und deren verwendung in medikamenten
ATE62683T1 (de) Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
ATE102210T1 (de) 1h,3h,7-pyrrolo (1,2-c>thiazolcarbonsaeureamidderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
FR2669029B1 (fr) Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
FI954394A (fi) 17-desoksikortikosteroidi-21-(O)-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä
ATE36710T1 (de) Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung.
EP0318029A3 (en) Cyclic amine and pharmacological composition
GR3000831T3 (en) Piperazine compounds, process for preparing them, pharmaceutical composition and use
HUT58097A (en) Process for producing 3,7-diazobicyclo(3,3.1)nonane compounds and pharmaceutical compositions comprising same
DE3886185D1 (de) 2-Thiazolidinon-Derivate und diese enthaltende pharmazeutische Präparate, Verfahren zu deren Herstellung und deren Verwendung.
DE69116423D1 (de) 3'-Deamino-4'-deoxy-4'-amino-8-fluoranthracycline und Verfahren zu ihrer Herstellung
DE3674250D1 (de) Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung.
DE3887611D1 (de) Butensäure-Amide, deren Salze, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
DE59105961D1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE104276T1 (de) Salze von acrylsaeure, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die sie enthalten und deren verwendung in der medizin.
FR2573428B1 (fr) Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.
DE69011952D1 (de) Physiologisch aktive Verbindungen SN-198C sowie Verfahren und Bakterien zu deren Herstellung.

Legal Events

Date Code Title Description
MM Patent lapsed